# Targeting Mitochondria: Strategies for Disease Treatment
> Learn about innovative mitochondrially-targeted therapies for cardiovascular, neurodegenerative, and metabolic diseases, including ALDH2 and mitophagy.

Tags: mitochondria, biotechnology, medical-research, cellular-metabolism, pharmacology, cardiovascular-health, neurodegeneration
## Mitochondrially-targeted Treatment Strategies
* Overview of emerging therapies for mitochondrial and non-mitochondrial diseases.
* Collaboration context: University of Sao Paulo and Stanford University.

## Mitochondria: The Powerhouse & Beyond
* Fundamental roles: ATP synthesis, redox balance, and apoptosis signaling.
* Pathological links: Key driver in neurodegeneration and cardiovascular failure.

## Regulation of Mitochondrial Metabolism
* Bioenergetics: ETC complexes I-V generate ATP via proton motive force.
* Signaling: Coordination via anterograde and retrograde signaling.
* Balance: Regulation of calcium flux and ROS/RNS balance.

## Mitochondrial Detoxifying Approaches
* Oxidative Stress: Generation of ROS like Superoxide and Hydrogen Peroxide.
* Aldehydic Toxicity: Lipid peroxidation leads to toxic aldehydes (e.g., 4-HNE).
* ALDH2 Activation Strategy: Using Alda-1 to enhance clearance of toxic aldehydes.

## Mitochondrial Dynamics & Quality Control
* Fusion Regulators: Mfn1, Mfn2, OPA1.
* Fission Regulators: Drp1, Fis1.
* Mitophagy: Quality control via the PINK1-Parkin pathway.

## Therapeutic Target: Cardiovascular Diseases
* Key conditions: Heart failure and ischemia-reperfusion injury.
* Targeted therapies: MitoQ, MTP-131 (Elamipretide), Alda-1.
* Peptides: P110 (Fission inhibitor) and SAMβA (Fusion promoter).
* Strategy: Mitochondrial transplantation.

## Therapeutic Targets: Neurodegenerative & Metabolic
* Neurodegenerative: Alzheimer's, Parkinson’s, ALS, Huntington’s using MitoQ, Resveratrol, NAD+ precursors.
* Metabolic: Obesity, Type 2 Diabetes using Metformin, Thiazolidinediones, NAD+ precursors.

## Targeted Pain Relief & Inherited Diseases
* Chronic Pain: Targeting mPTP (Olesoxime), p53 inhibition, and fission blockers.
* Inherited Diseases: Friedreich’s Ataxia, LHON, MELAS using Idebenone and EPI-743.

## Summary & Perspectives
* Mitochondria serve as central transducers of health.
* Emerging targets focus on bioenergetics, morphology, and clearance.
* Transitioning from preclinical success to clinical trial challenges.
---
This presentation was created with [Bobr AI](https://bobr.ai) — an AI presentation generator.